← Back to Search

Other

A novel digital health device for Alzheimer's Disease

N/A
Waitlist Available
Led By Mandy Salomon, PhD
Research Sponsored by Mentia DTx
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a video game that helps people with Alzheimer's practice daily tasks in a fun way. It aims to make these tasks easier in real life by using a virtual environment. The game targets those who struggle with daily activities due to dementia.

Eligible Conditions
  • Alzheimer's Disease
  • Dementia
  • Neurodegenerative Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL- severe)
The Neuropsychiatric Inventory - Nursing Home Version (NPI-NH) The minimum and maximum values are A higher score means a better or worse outcome.
Secondary study objectives
Approaches to Dementia Questionnaire (ADQ)
Sense of Competence in Dementia Care Staff (SCIDS) scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Persons residing in long-term care homesExperimental Treatment1 Intervention
Subjects' ADLs are studied with intervention compared to baseline (without intervention).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
A novel digital health device
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Mentia DTxLead Sponsor
National Institute on Aging (NIA)NIH
1,788 Previous Clinical Trials
28,184,514 Total Patients Enrolled
Mandy Salomon, PhDPrincipal InvestigatorMentia DTx

Media Library

A novel digital health device (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05418296 — N/A
Alzheimer's Disease Research Study Groups: Persons residing in long-term care homes
Alzheimer's Disease Clinical Trial 2023: A novel digital health device Highlights & Side Effects. Trial Name: NCT05418296 — N/A
A novel digital health device (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05418296 — N/A
~8 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top